The first author is also responsible for adhering to the ASCO’s Policy For Relationships With Companies (Conflict of Interest), obtaining disclosure information from all coauthors, and ensuring that all coauthors meet the definition of authorship as stated by the International Committee of Medical Journal Editors.
ASCO’s Policy For Relationships With Companies
*For questions regarding the 2013 ASCO Policy For Relationships With Companies, please see the FAQ page.
In compliance with standards established by the ASCO’s Policy For Relationships With Companies (Conflict of Interest; J Clin Oncol. 2013;31:2043–2043) and the Accreditation Council for Continuing Medical Information (ACCME), ASCO’s intent is to promote balance, independence, objectivity, and scientific rigor through the disclosure of financial and other interests, and in the identification and management of potential conflicts. According to the ASCO’s Policy For Relationships With Companies, all authors are expected to provide general disclosure information for 11 disclosure categories of relationships with for-profit health care companies.
The requirements in ASCO Conflict of Interest Policy apply to all abstract authors. Authors may enter their own disclosures using the ASCO Disclosure Management System online at coi.asco.org. By establishing a disclosure on coi.asco.org, authors will have a unified disclosure across all ASCO activities, including volunteer service, journals, and abstracts submissions. If an author has provided disclosure through ASCO Disclosure Management System, the information will automatically populate in the submission site.
Alternatively, a submitting author can enter disclosure information from coauthors who opt not to use the ASCO Disclosure Management System through the Abstract Submitter program. Copies of the Disclosure Form can be sent to coauthors for completion and returned to the submitting author before submission of the abstract.
Per the Implementation Plan to Manage Relationships with Companies for CME Activities, all oral abstract presenters will be subject to the same disclosure review and management strategies as faculty who participate in ASCO CME activities.
Please visit asco.org/rwc for more information on the ASCO Conflict of Interest Policy and the Conflict of Interest Policy Implementation Plan for CME Activities.
Additional Disclosure Questions for First, Last, and Corresponding Authors of Original Research
The first, last, and corresponding authors are required to answer additional questions specific to their abstract. ASCO will not enforce restrictions listed in ASCO’s Policy For Relationships With Companies on first, last, and corresponding authors and will reconsider whether to do so after a period of data gathering and analysis that will continue at least through April 22, 2016. Financial relationships of first, last, and corresponding authors are still required to be disclosed and will be managed in accordance with ASCO procedures.
Definition of Authorship
Abstracts submitted to the ASCO Annual Meeting must adhere to the definition of authorship as stated in the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals.” According to this document, “authorship credit should be based only on (1) substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; (2) drafting the article or revising it critically for important intellectual content; and (3) final approval of the version to be published. Conditions 1, 2, and 3 must all be met. Acquisition of funding, the collection of data, or general supervision of the research group, by themselves, do not justify authorship” (icmje.org).